Carbohydrate metabolism disease
MONDO:0037792A disease that has its basis in the disruption of carbohydrate metabolic process.
Also known as: carbohydrate metabolic process disease, disorder of carbohydrate metabolic process, disorder of carbohydrate metabolism
384 clinical trials for this condition and its sub-types, 4 tagged with Carbohydrate metabolism disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Carbohydrate metabolism disease
-
Inborn carbohydrate metabolic disorder 3 trials · 369 incl. sub-types
18 sub-types
- Disorder of carbohydrate transmembrane transport and absorption 0 trials · 162 incl. sub-types Sub-types →
- Disorder of glycogen metabolism 15 trials · 69 incl. sub-types Sub-types →
- Mucopolysaccharidosis 14 trials · 61 incl. sub-types Sub-types →
- Disorder of glycolysis 1 trial · 27 incl. sub-types Sub-types →
- Primary hyperoxaluria 13 trials · 17 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia 2 trials · 14 incl. sub-types Sub-types →
- Oligosaccharidosis 0 trials · 11 incl. sub-types Sub-types →
- Lactose intolerance 9 trials · 10 incl. sub-types Sub-types →
- G6PD deficiency 6 trials Sub-types →
- GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose metabolism 0 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose and fructose metabolism 0 trials · 4 incl. sub-types Sub-types →
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- Multiple carboxylase deficiency 0 trials · 3 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 1 2 trials
- Disorder of fructose metabolism 0 trials · 1 incl. sub-types Sub-types →
- Disorder of gluconeogenesis 0 trials · 1 incl. sub-types Sub-types →
- Disorders of pentose/polyol metabolism 0 trials · 1 incl. sub-types Sub-types →
-
Carbohydrate transport disease 0 trials · 156 incl. sub-types
2 sub-types
- Glucose transport disorder 1 trial · 156 incl. sub-types Sub-types →
- GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types Sub-types →
-
Scurvy 13 trials
-
Intestinal disaccharidase deficiency 0 trials · 2 incl. sub-types
1 sub-type
-
Glycerol metabolism disease 0 trials
Most studied deeper sub-types
-
Obesity drug cocktail tested for heart benefits – study halted early
Disease control Stopped earlyThis study looked at whether using a combination of weight-loss medications could help people with obesity lose weight and improve the health of their blood vessels. It involved 128 adults aged 40-75 who were obese and had at least one heart risk factor. The study was stopped ear…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Pompe disease drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested an oral drug called duvoglustat in adults with Pompe disease, a rare genetic disorder that causes muscle weakness. Only 3 people took part, and the study was stopped early. Researchers looked at safety and whether the drug could improve walking distance and othe…
Phase 2 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC